Narrative Intervention for Long COVID-19 (NICO)
NCT06091293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2024-12-10
Summary
This T1 proof of concept trial is designed to test the Narrative Intervention for Long COVID-19 intervention.
Conditions
- Long COVID
- Long Covid19
Interventions
- BEHAVIORAL
-
Narrative Intervention for Long COVID-19 (NICO)
The NICO intervention was delivered by a licensed psychotherapist asynchronously over a 3 month time period.
Sponsors & Collaborators
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Rachel Johnson, PhD, LCSW · University of Colorado, Denver
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2022-12-01
- Completion
- 2022-12-01
Countries
- United States
Study Locations
More Related Trials
-
The Natural History of Hospitalized COVID-19 Patients
NCT04424992 ·Status: RECRUITING
-
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
NCT00001477 ·Status: COMPLETED
-
International SARS-CoV-2 (COVID-19) Infection Observational Study
NCT04385251 ·Status: COMPLETED
-
Sensitivity Evaluation of Serological Tests for Covid-19
NCT04678024 ·Status: UNKNOWN
-
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
NCT04331795 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
NCT04912895 ·Status: COMPLETED ·Phase: NA
-
Differential Leucocyte Count and Covid-19 Diagnosis
NCT04643860 ·Status: WITHDRAWN
-
Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2
NCT05596032 ·Status: COMPLETED
-
Health Professional Exposure Assessment to Covid-19
NCT04429724 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct Assay
NCT04785898 ·Status: COMPLETED ·Phase: NA
-
Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations
NCT05667597 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Corticosteroids for COVID-19
NCT04795583 ·Status: WITHDRAWN ·Phase: PHASE3
-
Dynamic Evaluation of COVID-19 Diagnostic Tests
NCT04337996 ·Status: COMPLETED ·Phase: NA
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia
NCT04359511 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study
NCT05258643 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Close Contact Self-Testing Study
NCT04847479 ·Status: COMPLETED ·Phase: NA
-
Survey of Incidence of Respiratory Tract Infections
NCT06649032 ·Status: COMPLETED
-
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 ·Status: COMPLETED
-
Immunophenotyping Assessment in a COVID-19 Cohort
NCT04378777 ·Status: COMPLETED
-
Education of Medical Staff to Post Acute Covid susTained sYmptoms
NCT06082258 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
NCT06597396 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
NCT05844410 ·Status: COMPLETED
-
Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19
NCT04765371 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19
NCT04924829 ·Status: UNKNOWN